Simple Summary Dedifferentiated chondrosarcoma is a rare type of cancer that is very
aggressive and has a poor prognosis with poor survival rates. This disease can affect …

Simple Summary Dedifferentiated chondrosarcoma (DDCS) is a rare cancer that is
aggressive and leads to high patient mortality. There are limited data on the efficacy of …

Background: Dedifferentiated chondrosarcoma (DDC) accounts for a small proportion of
chondrosarcomas. They demonstrate aggressive behaviour with a high rate of local …

Abstract Purpose of Review The pathogenesis of dedifferentiated chondrosarcoma is
controversial, and no genetic abnormality has consistently been identified in the disease …

Dedifferentiated chondrosarcomas are aggressive variants of chondrosarcoma, associated
with poor outcomes. Tumor biphasism is the norm. The majority of these tumors are …

Background. Dedifferentiated chondrosarcomas (DDCSs) are highly malignant tumors with
a dismal prognosis and present a significant challenge in clinical management. Methods. In …

Background and Objectives Dedifferentiated chondrosarcoma is a rare malignancy with
reported 5‐year overall survival rates ranging from 7% to 24%. The purpose of this …

Background Dedifferentiated chondrosarcoma (DCS) is a rare and aggressive malignancy
with a poor prognosis. The purpose of this investigation was to describe our treatment and …

Background We report on 13 patients with dedifferentiated chondrosarcomas. The mean
age of the patients at diagnosis was 59.8 years. Nine patients were classified as stage IIB …

Dedifferentiated chondrosarcoma (DDCS) is a high-grade subtype of chondrosarcoma with
the bimorphic histological appearance of a conventional chondrosarcoma component with …